Tadataka yamada biography

Yamada was the author of more than 150 original manuscripts on the subject and won innumerable awards for contribution to the field, including the SmithKline & French Award for Distinguished Achievement in Gastrointestinal Physiology from the American Physiological Society.
Www.michiganmedicine.org › Medicine At Michigan.
Tachi was a scientist, an entrepreneur, an outstanding mentor, a leader in academic medicine and global health, and an industry pioneer.

•

Residency: Oct. 3-7, 2016

Public Talk:
"Biomedical Research: Lessons from Global Health"
Oct. 5, 2016
Sir Tadataka Yamada, the former director of the Bill & Melinda Gates Foundation Global Health Program, discussed key global health issues and current trends of biomedical research and its impact.

Biography

Sir Tadataka Yamada is the life sciences team venture partner and growth buyout team senior advisor at Frazier Healthcare Partners. Before his current role, Sir Yamada was the chairman of research and development at GlaxoSmithKline PLC, director of global health at the Bill & Melinda Gates Foundation, as well as chief scientific officer at Takeda Pharmaceuticals Co. in Tokyo. As an extension of his work in entrepreneurship and medical development, Sir Yamada emphasizes the power of partnerships in health care between large pharmaceutical companies and philanthropic foundations.

During his residency, Sir Yamada held several meetings within the UC San Diego community, including GPS faculty and student groups, JFIT, Department of Bioengineering, School of Me

•

Tachi Yamada, Physician-Scientist-Biopharma Industry Leader, Dies at 76

Tadataka “Tachi” Yamada, a distinguished physician-scientist who became a biopharmaceutical industry leader and a deeply respected advisor to biotech entrepreneurs, died the morning of Aug. 4. He was 76.

Tachi Yamada

Yamada died from a heart attack while exercising at home in Seattle, said his son, Takao.

“He was a special person who did things to help people. That was his North Star,” his son said.

Yamada was a rare leader with experience in several dimensions of the scientific enterprise – academia, industry, and philanthropy. He was best known for high-profile roles later in his career as the chairman of R&D at GSK, the president of the $9 billion global health program at the Bill & Melinda Gates Foundation, and then as chief medical and scientific officer at Takeda Pharmaceuticals.

Those jobs came after Yamada made an early mark as a physician-scientist, specializing as a professor of gastroenterology at UCLA and then at the University of Michigan. He was elected by peers to National Academ

•

The World Takes Another Hit with Loss of Global Health Giant Dr. Tachi Yamada

Dr. Tadataka “Tachi” Yamada/Photo Courtesy of Getty Images.

In the midst of the biggest global health crisis in a generation, the world has lost one of its premier global public health advocates. Dr. Tadataka “Tachi” Yamada, a former GlaxoSmithKline and Takeda Pharmaceuticalexecutive, early gene therapy backer, and philanthropist, passed away on Wednesday of natural causes at the age of 76.

Born in Japan, Yamada eventually moved to the United States and trained as a gastroenterologist. He began his impactful career in academia where he rose to Chief of the Division of Gastroenterology and chair of the Department of Internal Medicine at the University of Michigan. He then made the pivot to the Life Sciences, becoming the Chairman of Research and Development for GSK.

Yamada made the decision to move into industry to make a more direct impact on patients.

“You’re working in the laboratory; you’re doing research that’s pretty basic. And you feel like this work is going to actually have an im